Endocrinology News and Research

Latest Endocrinology News and Research

Drug increases amount of energy burned by fat tissue and promotes weight loss

A drug that mimics the activity of thyroid hormone significantly increases the amount of energy burned by fat tissue and promotes weight loss, an animal study of metabolism finds. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

Increasing red meat intake boosts risk of type-2 diabetes mellitus

Eating more red meat over time is associated with an increased risk of type-2 diabetes mellitus (T2DM) in a follow-up of three studies of about 149,000 U.S. men and women, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

18 Jun 2013

Study: Male mice fed with high-fat diet are more likely to father offspring with higher levels of body fat

Male mice who were fed a high-fat diet and became obese were more likely to father offspring who also had higher levels of body fat, a new Ohio University study finds.

17 Jun 2013

Transition, Lilly amend agreement to address future development of TT-401

Transition Therapeutics Inc. announced that Eli Lilly and Company has exercised its option to assume all development and commercialization rights to type 2 diabetes drug candidate TT-401.

17 Jun 2013

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.

17 Jun 2013

Mount Sinai researchers present several new studies at ENDO 2013

Researchers from the Icahn School of Medicine at Mount Sinai will present several new studies at ENDO 2013, The Endocrine Society's Annual Meeting & Expo from June 15-18 in San Francisco.

17 Jun 2013

Researchers identify genetic mutation responsible for MDP Syndrome

National Paracycling Champion Tom Staniford has an extremely rare condition which, until now, has puzzled his doctors. He is unable to store fat under his skin - yet has type 2 diabetes - and suffered hearing loss as a child. Now, thanks to advances in genome sequencing, an international research team led by the University of Exeter Medical School has identified Tom's condition and pinpointed the single genetic mutation that causes it.

17 Jun 2013

Eli Lilly, BIPI support ADA's call for independent review of incretin-based therapies

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company support the American Diabetes Association call for an independent review of the safety data of incretin-based therapies.

17 Jun 2013

Bristol-Myers Squibb, AstraZeneca release statement on ADA's efforts toward incretin-based therapies

Earlier this week, the American Diabetes Association called for manufacturers of incretin-based therapies to make patient-level data available from clinical trials for an independent analysis of pancreatic safety.

17 Jun 2013

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

Pathway Genomics led the evening news Friday with an announcement that it could begin offering affordable access to genetic testing for the BRCA gene linked to breast and ovarian cancers in the wake of a Supreme Court ruling that eliminated another company's monopoly on the test.

15 Jun 2013

Amedra Pharmaceuticals re-launches single-dose epinephrine auto-injector, Adrenaclick

Amedra Pharmaceuticals LLC has announced re-launch of Adrenaclick®, a single-dose epinephrine auto-injector, for the emergency treatment of life threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Adrenaclick® will be available as a two-pack carton in both 0.15 mg and 0.30 mg strengths.

15 Jun 2013

Immigrants' health care costs are hot topic on Capitol Hill

Other media reports detail Sen. Ron Wyden's proposal to allow accountable care organizations to focus on the sickest, most costly patients; questions from Rep. Darrell Issa, R.-Calif., about the navigator program's funding; and House Minority Leader Nancy Pelosi's, D-Calif., angry response to a reporter's question about late-term abortions.

15 Jun 2013

ESH and ESC issue new joint Guidelines for hypertension treatment

Lifestyle factors, lack of awareness by both patients and physicians, hesitancy in initiating and intensifying drug treatment, and healthcare structural deficiencies are amongst the reasons for the increasing problem of high blood pressure in Europe, according to new joint Guidelines issued today by the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC).

15 Jun 2013

Too much sugar can lead to heart failure, shows study

Too much sugar can set people down a pathway to heart failure, according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).

15 Jun 2013

pSivida reports that NICE issues draft guidance for use of ILUVIEN for pseudophakic patients with DME

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the United Kingdom's National Institute for Health and Care Excellence issued draft guidance recommending ILUVIEN for the treatment of pseudophakic patients (those who have undergone prior cataract surgery) with chronic diabetic macular edema considered insufficiently responsive to available therapies.

15 Jun 2013

Anthem and SVHP to collaborate on new model of provider reimbursement

Anthem Blue Cross and Blue Shield and St. Vincent's Health Partners, Inc., announced today the collaboration on a new model of provider reimbursement. Under this new arrangement, SVHP will focus on the management of chronic disease and preventive health of their patients.

15 Jun 2013

Elcelyx Therapeutics' posters related to NewMet to be presented at ADA's 73rd Scientific Sessions

Elcelyx Therapeutics today announced that the company and principal investigator Ralph A. DeFronzo, M.D. will present posters related to NewMet, a delayed-release formulation of generic metformin, at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, IL.

15 Jun 2013

UTHealth collaborates with Rice University to save lives of CVD patients in Fiji

A device born out of a collaboration between The University of Texas Health Science Center at Houston (UTHealth) and Rice University could save lives in Fiji where cardiovascular disease has been called a pandemic.

14 Jun 2013

Researchers are one step closer to treating type 1 diabetes

Researchers at Washington University School of Medicine in St. Louis have identified a way to trigger reproduction in the laboratory of clusters of human cells that make insulin, potentially removing a significant obstacle to transplanting the cells as a treatment for patients with type 1 diabetes.

14 Jun 2013

Pew funds early-career scientists researching the basis of perplexing health problems

Twenty-two of the nation's most enterprising researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems such as diabetes, autism, Parkinson's disease, and cancer.

14 Jun 2013

Endocrinology News and Research

Latest Endocrinology News and Research

Drug increases amount of energy burned by fat tissue and promotes weight loss

Increasing red meat intake boosts risk of type-2 diabetes mellitus

Study: Male mice fed with high-fat diet are more likely to father offspring with higher levels of body fat

Transition, Lilly amend agreement to address future development of TT-401

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

Mount Sinai researchers present several new studies at ENDO 2013

Researchers identify genetic mutation responsible for MDP Syndrome

Eli Lilly, BIPI support ADA's call for independent review of incretin-based therapies

Bristol-Myers Squibb, AstraZeneca release statement on ADA's efforts toward incretin-based therapies

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

Amedra Pharmaceuticals re-launches single-dose epinephrine auto-injector, Adrenaclick

Immigrants' health care costs are hot topic on Capitol Hill

ESH and ESC issue new joint Guidelines for hypertension treatment

Too much sugar can lead to heart failure, shows study

pSivida reports that NICE issues draft guidance for use of ILUVIEN for pseudophakic patients with DME

Anthem and SVHP to collaborate on new model of provider reimbursement

Elcelyx Therapeutics' posters related to NewMet to be presented at ADA's 73rd Scientific Sessions

UTHealth collaborates with Rice University to save lives of CVD patients in Fiji

Researchers are one step closer to treating type 1 diabetes

Pew funds early-career scientists researching the basis of perplexing health problems

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Endocrinology News and Research

Latest Endocrinology News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in